Neuroprotective Compound Composition for Blood-Brain Barrier Penetration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There are no proven methods or medicaments to effectively prevent and treat neurodegeneration diseases, which are caused by complex interactions of factors leading to neurological dysfunction and cell death.
Innovation Solution
Development of a novel compound represented by specific formulae (I)-(V), or its tautomers, stereoisomers, or pharmaceutically acceptable salts, which exhibit neuroprotective properties and are designed to target multiple pathways associated with neurodegeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional medicaments are used to treat neurodegeneration diseases, then treatment is provided, but there are no proven methods or medicaments to effectively prevent and treat the disease
Solution Approach 1:
The patent modifies molecular parameters of neuroprotective compounds by adjusting substituent groups (R1-R6, X1-X2) in the chemical structure to optimize activity against neurodegeneration while maintaining safety profile
Solution Approach 2:
The invention creates composite pharmacological agents combining multiple functional groups within a single molecule to simultaneously address multiple pathways involved in neurodegeneration, achieving multi-targeted therapy
2Reliability
If a novel compound is developed to target multiple pathways, then treatment effectiveness is improved, but the complexity of the compound structure increases
Solution Approach 1:
The patent designs a universal molecular framework that can simultaneously interact with multiple target pathways (glutamate receptors, mitochondrial function, oxidative stress) through strategically placed functional groups, achieving multi-functionality without proportionally increasing structural complexity
Solution Approach 2:
The compound structure is segmented into distinct functional modules: a core scaffold and interchangeable substituent groups (R1-R6), allowing systematic variation to optimize different biological activities while maintaining an organized, manageable structure
3Ease of operation
If the compound is designed to cross the blood-brain barrier easily, then neuroprotective effect is enhanced, but pharmacokinetic properties may be compromised
Solution Approach 1:
The patent optimizes physicochemical parameters of the compound including molecular weight, lipophilicity, and hydrogen bonding capacity to facilitate blood-brain barrier penetration while maintaining acceptable pharmacokinetic properties through balanced structural design
Data Source
AI summary
A novel compound, a pharmaceutical composition thereof, and use thereof. The novel compound is represented by formula (I), wherein the details of the definition of each substituent group are shown in the specification. The compound can be used for preparing a medicament for preventing or treating a neurodegeneration disease and a cardiovascular and cerebrovascular disease.